(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

President Biden Commends Historic Tentative Agreement Between Culinary Union and Major Las Vegas Resorts

November 11th, 2023

President Joe Biden has extended his congratulations to the Culinary and Bartenders Unions for their collaborative efforts in reaching a tentative agreement with MGM Resorts, Caesars Entertainment, and Wynn Resorts. The President commended the unions. Read more

D.R. Horton, Datadog, and MannKind Earnings On Deck: A Preview

November 05th, 2023

On Tuesday, November 7, several companies are set to report their financial results, including: D.R. Horton, Inc. (NYSE: DHI), a prominent home construction company, will unveil its financial results for the fourth quarter and fiscal year 2023 bef. Read more

Earnings Countdown: NXP Semiconductors, Gerdau, and Freshpet Take The Stage

November 05th, 2023

On Monday, November 6, a series of companies are gearing up to release their financial results, including: NXP Semiconductors N.V. (Nasdaq: NXPI), a prominent semiconductor manufacturer, will unveil its financial results for the third quarter of 2. Read more

A Preview: Sony Group, Archer Aviation, and Microvast Earnings Due

November 05th, 2023

On Thursday, November 9, several companies are poised to unveil their financial reports, including: Sony Group Corporation (NYSE: SONY), a multinational conglomerate, is geared to disclose its second-quarter fiscal 2023 earnings results before the. Read more

Earnings Watch: Walt Disney, Biogen, and Fair Isaac Set To Unveil

November 04th, 2023

On Wednesday, November 8, several notable companies are slated to disclose their financial performance, including: The Walt Disney Company (NYSE: DIS), a leading entertainment conglomerate, will present its fiscal full-year and fourth-quarter 2023. Read more

Earnings In Focus: Gilead Sciences, Uber, and Lucid Group Gear Up

November 04th, 2023

On Tuesday, November 7, several significant companies are slated to unveil their financial results, including: Gilead Sciences, Inc. (Nasdaq: GILD), a leading biopharmaceutical company, will release its third-quarter 2023 financial results and gui. Read more

Ryanair, Vertex Pharmaceuticals, and Celanese's Earnings Preview

November 04th, 2023

On Monday, November 6, several notable companies are set to disclose their financial reports, including: Ryanair Holdings plc (Nasdaq: RYAAY), a leading international airline, is poised to reveal its second-quarter and first-half fiscal 2024 finan. Read more

Roku's Q3 Revenue Beats Expectations; Nutrien Misses Estimates

November 01st, 2023

Roku, Inc. (Nasdaq: ROKU) reported a third-quarter 2023 loss of $(2.33) per share, falling short of the consensus estimate loss of $(2.08) per share. Despite the loss, the company's quarterly revenues reached $912.02 million, surpassing analysts' exp. Read more

October Vehicle Delivery: Li Auto, XPeng, and NIO By The Numbers

November 01st, 2023

In the electric vehicle industry, major players such as Li Auto Inc. (Nasdaq: LI), XPeng Inc. (NYSE: XPEV), and NIO Inc. (NYSE: NIO) have reported their vehicle delivery figures for October 2023. Li Auto achieved a milestone by delivering 40,422 v. Read more

Tonix Pharma's TNX-601 ER Trial Misses Endpoint; AMD Posts Upbeat Results

November 01st, 2023

Shares of Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) experienced a drastic over 20% decline in after-hours trading following the release of Phase 2 proof-of-concept study results for TNX-601 ER, intended for patients with major depressive dis. Read more